Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, April 12, 2024
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
[ Fri, Apr 12th 2024
] - WOPRAI
Thu, April 11, 2024
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
Brian Abrahams Reiterated (APLT) at Buy and Held Target at $12 on, Apr 11th, 2024
Brian Abrahams of RBC Capital, Reiterated "Applied Therapeutics, Inc." (APLT) at Buy and Held Target at $12 on, Apr 11th, 2024.
Brian has made no other calls on APLT in the last 4 months.
There are 3 other peers that have a rating on APLT. Out of the 3 peers that are also analyzing APLT, 0 agree with Brian's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Brian
- Esther Rajavelu of "UBS" Maintained at Strong Buy with Increased Target to $13 on, Friday, March 15th, 2024
- Joseph Schwartz of "Leerink Partners" Initiated at Buy and Held Target at $12 on, Thursday, February 22nd, 2024
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $7 on, Friday, February 16th, 2024
